Pakistan drug serialization: DRAP track and trace from 9 October 2026.
In Pakistan, DRAP's Pharmaceutical Track and Trace System has required a 2D Data Matrix barcode and serial number on all locally manufactured and imported pharmaceutical products since 9 October 2026, under S.R.O. 963(I)/2026 amending the Drugs (Labelling and Packing) Rules, 1986.
Pakistan's drug serialization rule is in force. S.R.O. 963(I)/2026 of 9 June 2026 amended the Drugs (Labelling and Packing) Rules, 1986, and since 9 October 2026 DRAP requires a unique 2D Data Matrix barcode and serial number on all locally manufactured and imported pharmaceutical products. Batches with an earlier manufacturing date are exempt.
Pakistan, in three facts.
Pakistan · Drug Regulatory Authority of Pakistan (DRAP) · S.R.O. 963(I)/2026 of 9 June 2026 amends the Drugs (Labelling and Packing) Rules, 1986 · 2D Data Matrix and serial number from 9 October 2026.
Pakistan's Drug Regulatory Authority (DRAP) amended the Drugs (Labelling and Packing) Rules, 1986 by S.R.O. 963(I)/2026 of 9 June 2026, making its Pharmaceutical Track and Trace System, with a 2-D barcode and serialisation, mandatory from 9 October 2026 for all pharmaceutical products for human and veterinary use.
Source: DRAP, O.M. No. 28/2026-DIR(MIS), Implementation of Track and Trace System: Amendments in Drugs (Labelling and Packing) Rules, 1986 (11 June 2026)DRAP's circular of 8 October 2026 says phase 1 of the track and trace system covers all locally manufactured and imported pharmaceutical products, each needing a unique 2D Data Matrix barcode and serial number from 9 October 2026; batches manufactured or imported with a manufacturing date before 9 October 2026 are exempt and remain permitted for import, distribution and sale.
Source: DRAP, Circular F. No. 1-2/2026-CEO(DRAP), Compliance of 2D Barcoding and Serialization (Track and Trace System) (8 October 2026)DRAP's directive of 25 August 2026 extended to 5 September 2026 the deadline for verifying and validating licensing and product data on its eApp software for integration with the track and trace system.
Source: DRAP, O.M. No. 52/2026-Dir(MIS), Directive for Mandatory Data Validation on eApp Software for Integration with Track and Trace System (25 August 2026)
A serial on every pack, made here or imported.
The rule
S.R.O. 963(I)/2026 of 9 June 2026 amended the Drugs (Labelling and Packing) Rules, 1986. It made DRAP's Pharmaceutical Track and Trace System, with a 2-D barcode and serialisation, mandatory from 9 October 2026, four months after the notification, for pharmaceutical products for human and veterinary use.
Phase 1: local and imported products
DRAP's circular of 8 October 2026 says phase 1 covers all locally manufactured and imported pharmaceutical products. Each needs a unique 2D Data Matrix barcode and serial number, following DRAP's guidelines on GS1 Data Matrix barcodes and serialisation.
Older batches are exempt
Batches manufactured locally or imported with a manufacturing date before 9 October 2026 are exempt and remain permitted for import, distribution and sale. DRAP says it will take legal action for non-compliance.
Data through eApp
Before launch, DRAP required licensing and product data to be verified and validated on its eApp software for integration with the track and trace system, with the deadline extended to 5 September 2026.
The timeline, as it stands.
DRAP describes the system as rolled out in phases. Phase 1 covers locally manufactured and imported pharmaceutical products; check DRAP's notifications before planning for later phases.
Three moves that de-risk the deadline.
Check every product you ship to Pakistan
Imports are covered: any batch made or imported with a manufacturing date on or after 9 October 2026 needs the 2D Data Matrix and serial number.
Keep your eApp data clean
The track and trace system draws on the licensing and product data held in DRAP's eApp. Errors there show up as failed checks downstream.
Serve other markets from the same data
Plants that supply Pakistan, the EU and the US print a 2D code for each. One serialisation design can serve all three.
A serial, and proof behind it.
A serial number tells a pharmacist which pack it should be, and a copied code tells them the same thing. Aeroz adds an identity to the pack or case that answers each tap with a signed response, so a distributor or pharmacist can tell the genuine product from a pack carrying a copied code.
Pakistan, answered.
What is DRAP's drug serialization requirement?
Under S.R.O. 963(I)/2026, which amended the Drugs (Labelling and Packing) Rules, 1986, every locally manufactured or imported pharmaceutical product needs a unique 2D Data Matrix barcode and serial number from 9 October 2026, reported through DRAP's Pharmaceutical Track and Trace System.
From when is the 2D barcode mandatory in Pakistan?
From 9 October 2026, four months after the notification of 9 June 2026.
Does it apply to imported medicines?
Yes. DRAP's circular of 8 October 2026 says phase 1 covers locally manufactured and imported pharmaceutical products alike.
What happens to stock made before 9 October 2026?
Batches manufactured or imported with a manufacturing date before 9 October 2026 are exempt and remain permitted for import, distribution and sale.
Know exactly where you stand, in 14 days.
A fixed-fee Aeroz audit maps your products against Pakistan's DRAP track and trace, 2D barcode and serialisation requirements and returns a written readiness assessment, a data-mapping review, and a scoped pilot plan with cost and timeline.